| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8778519 | European Urology | 2018 | 8 Pages |
Abstract
Prostate cancer screening reduces mortality but is accompanied by unnecessary biopsies and overdiagnosis of nonaggressive tumors, especially in repeatedly screened elderly men. To tackle these drawbacks screening should consist of an upfront risk-assessment followed by magnetic resonance imaging and transrectal ultrasound-guided biopsy.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Arnout R. Alberts, Ivo G. Schoots, Leonard P. Bokhorst, Frank-Jan H. Drost, Geert J. van Leenders, Gabriel P. Krestin, Roy S. Dwarkasing, Jelle O. Barentsz, Fritz H. Schröder, Chris H. Bangma, Monique J. Roobol,